Eurofins Scientific SE (ERF) - Total Assets

Latest as of December 2025: €10.98 Billion EUR ≈ $12.84 Billion USD

Based on the latest financial reports, Eurofins Scientific SE (ERF) holds total assets worth €10.98 Billion EUR (≈ $12.84 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See what is Eurofins Scientific SE's book value for net asset value and shareholders' equity analysis.

Eurofins Scientific SE - Total Assets Trend (2002–2025)

This chart illustrates how Eurofins Scientific SE's total assets have evolved over time, based on quarterly financial data.

Eurofins Scientific SE - Asset Composition Analysis

Current Asset Composition (December 2025)

Eurofins Scientific SE's total assets of €10.98 Billion consist of 24.2% current assets and 75.9% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 7.2%
Accounts Receivable €1.54 Billion 14.0%
Inventory €139.00 Million 1.3%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €690.00 Million 6.3%
Goodwill €4.66 Billion 42.4%

Asset Composition Trend (2002–2025)

This chart illustrates how Eurofins Scientific SE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ERF stock market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Eurofins Scientific SE's current assets represent 24.2% of total assets in 2025, a decrease from 40.7% in 2002.
  • Cash Position: Cash and equivalents constituted 7.2% of total assets in 2025, up from -1.8% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 48.0% of total assets, an increase from 31.0% in 2002.
  • Asset Diversification: The largest asset category is goodwill at 42.4% of total assets.

Eurofins Scientific SE Competitors by Total Assets

Key competitors of Eurofins Scientific SE based on total assets are shown below.

Company Country Total Assets
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Eurofins-Cerep SA
PA:ALECR
France €84.58 Million
Inoviq Ltd
AU:IIQ
Australia AU$24.52 Million
Bcal Diagnostics Ltd
AU:BDX
Australia AU$7.17 Million
Imagion Biosystems Ltd
AU:IBX
Australia AU$932.48K
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Monash Ivf Group Ltd
AU:MVF
Australia AU$510.21 Million

Eurofins Scientific SE - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.09 1.16 1.48
Quick Ratio 1.03 1.09 1.39
Cash Ratio 0.33 0.29 0.00
Working Capital €223.00 Million €342.00 Million €821.80 Million

Eurofins Scientific SE - Advanced Valuation Insights

This section examines the relationship between Eurofins Scientific SE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.43
Latest Market Cap to Assets Ratio 1.05
Asset Growth Rate (YoY) 0.9%
Total Assets €10.98 Billion
Market Capitalization $11.53 Billion USD

Valuation Analysis

Above Book Valuation: The market values Eurofins Scientific SE's assets above their book value (1.05x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Eurofins Scientific SE's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Eurofins Scientific SE (2002–2025)

The table below shows the annual total assets of Eurofins Scientific SE from 2002 to 2025.

Year Total Assets Change
2025-12-31 €10.98 Billion
≈ $12.84 Billion
+0.89%
2024-12-31 €10.89 Billion
≈ $12.73 Billion
0.00%
2023-12-31 €10.89 Billion
≈ $12.73 Billion
+7.98%
2022-12-31 €10.08 Billion
≈ $11.79 Billion
+8.05%
2021-12-31 €9.33 Billion
≈ $10.91 Billion
+8.83%
2020-12-31 €8.58 Billion
≈ $10.03 Billion
+9.62%
2019-12-31 €7.82 Billion
≈ $9.15 Billion
+8.57%
2018-12-31 €7.21 Billion
≈ $8.42 Billion
+23.54%
2017-12-31 €5.83 Billion
≈ $6.82 Billion
+41.24%
2016-12-31 €4.13 Billion
≈ $4.83 Billion
+11.61%
2015-12-31 €3.70 Billion
≈ $4.33 Billion
+97.52%
2014-12-31 €1.87 Billion
≈ $2.19 Billion
+25.13%
2013-12-31 €1.50 Billion
≈ $1.75 Billion
+29.15%
2012-12-31 €1.16 Billion
≈ $1.36 Billion
+7.87%
2011-12-31 €1.07 Billion
≈ $1.26 Billion
+45.97%
2010-12-31 €736.16 Million
≈ $860.65 Million
+11.66%
2009-12-31 €659.30 Million
≈ $770.79 Million
-10.18%
2008-12-31 €734.01 Million
≈ $858.13 Million
+19.93%
2007-12-31 €612.02 Million
≈ $715.52 Million
+32.95%
2006-12-31 €460.34 Million
≈ $538.18 Million
+72.95%
2005-12-31 €266.16 Million
≈ $311.17 Million
+39.99%
2004-12-31 €190.12 Million
≈ $222.28 Million
+14.20%
2003-12-31 €166.48 Million
≈ $194.63 Million
+3.88%
2002-12-31 €160.26 Million
≈ $187.36 Million
--

About Eurofins Scientific SE

PA:ERF France Diagnostics & Research
Market Cap
$12.15 Billion
€10.40 Billion EUR
Market Cap Rank
#2001 Global
#42 in France
Share Price
€59.02
Change (1 day)
+2.57%
52-Week Range
€54.66 - €73.12
All Time High
€121.25
About

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more